Ranbaxy

Ranbaxy, Russian region sign MoU on healthcare cooperation

31 Jan 2011

Merck and Ranbaxy end drug development pact

06 Jan 2011

Ranbaxy arm in $134-million AIDS drug supply deal with South African government

20 Dec 2010

Ranbaxy registers 168 per cent leap in end-Sept profit

12 Nov 2010

Atul Sobti quits as Ranbaxy MD & CEO; Arun Sawhney steps in as MD, leaving CEO slot vacant

12 Aug 2010

Atul Sobti, CEO and MD of Ranbaxy has resigned following differences with parent Daiichi Sankyo, about a year after his elevation to the top spot, following the resignation of Malvinder Singh

Ranbaxy recalls nerve pain drug from UK market

04 Jun 2010

Ranbaxy boosts Daiichi Sankyo’s Q1 profits

13 May 2010

Ranbaxy posts spectacular profit from last year's loss

11 May 2010

Ranbaxy recalls two consignments of drugs from US market

15 Apr 2010

Ranbaxy, Dow arm tie up to develop biosimilar protein

29 Mar 2010

US FDA rejects Ranbaxy's application for generic Flomax

03 Mar 2010

Ranbaxy swings back to profit

25 Feb 2010

Ranbaxy Laboratories today reported a net profit of Rs488.23 crore in October-December 2009, against a net loss of Rs819 crore in the comparable quarter of the previous year.

US FDA asks Ranbaxy to ensure plant standards compliance: report

05 Feb 2010

Ranbaxy acquires Biovel to enter vaccines business

19 Jan 2010

Ranbaxy sells Chinese JV stake to state-owned firm

29 Dec 2009

Ranbaxy again feels FDA heat – this time over US plant

26 Dec 2009

Ranbaxy to launch anti-hypertensive drug in six African countries

21 Dec 2009

The product to be marketed under the brand name Olvance would be launched immediately on completion of the required formalities in each country

Ranbaxy exits JV with Japan’s Nippon Chemiphar

09 Dec 2009

Ranbaxy launches generic herpes drug in US

27 Nov 2009

Ranbaxy posts Rs186.08 crore in Q2 profits

27 Oct 2009

EU official raid Ranbaxy French unit

08 Oct 2009

Securities Tribunal asks Daiichi to offer Rs160 per Zenotech share

08 Oct 2009

Daiichi, through its acquisition of controlling stake of 64 per cent in Ranbaxy Laboratories last year, holds 47 per cent stake in Zenotech.

Ranbaxy to market Daiichi Sankyo products in Mexico

05 Oct 2009

Ranbaxy in-licenses cosmetic product Neuronox from Medy-Tox, South Korea

17 Sep 2009

Ranbaxy launches authorised generic version of Validus's Rocaltrol

03 Sep 2009

View details about the software product Informachine News Trackers